TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). In addition, it is developing TG-1701 (BTK inhibitor), Azer-Cel (allogeneic CD19 CAR T), and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders, which are under Phase 1 trials. Geographically, the company generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from sales in other countries.
Quick Stats
Jan 30, 202656.5
AI Score
HOLD0.94
Volume Ratio
Mar 02, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
TGTX Stock Summary
Last updated Jan 30, 2026
TGTX is currently trading at $29.43, positioned below its 200-day moving average of $33.67, suggesting bearish momentum. The stock has a 52-week range of $25.28 to $46.48.
Technical Analysis: The 50-day moving average stands at $30.73, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 43.023, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.141, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates TGTX at 56.5/100 with a HOLD recommendation.
TGTX (TG Therapeutics, Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 43.023 |
| CMF (20) | -0.141 |
| ROC (10) | -4.168 |
| ADX (14) | 20.425 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.088 |
| AROONOSC (14) | 7.143 |
| WILLAMS %R (14) | -60.0 |
| MFI (14) | 66.497 |
TGTX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
TGTX Price vs Max Options Open Interest
TGTX Max Change In Options Open Interest
TGTX Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TGTX Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TGTX Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TGTX Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TG Therapeutics, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
TGTX Moving Averages Analysis
TGTX (TG Therapeutics, Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 30.74 |
| 20 | 30.06 |
| 30 | 30.22 |
| 50 | 30.73 |
| 100 | 32.3 |
| 200 | 33.67 |
TGTX Fundamental Analysis
| P/E (Forward) | 24.0385 |
| P/E (Trailing) | 10.9422 |
| Market Cap ($) | 4.8 billion |
| Earnings/Share ($) | 2.77 |
| Net Proft Margin (%) | 0.8413 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 2.9977 |
| EPS Estimate Next Year ($) | 1.7751 |
| WallStreet Target Price ($) | 44.8571 |
| Most Recent Quarter |
News Summary: $TGTX stock price closed at $20.08 on Yahoo Finance, showing potential for growth. Investors are optimistic about the stock reaching $45 soon. Additionally, there is discussion about OTM puts being sold, prompting experts to review and provide insights.
Updated 2025-08-15 15:00:02